Children with Covid-associated MIS-C display unique immunological profile

Olink has created a summary article of a study recently published by Consiglio et al. in Cell.

This study focuses on the rare cases when children develop Multisystem Inflammatory Syndrome in Children (MIS-C) in response to infection by the SARS-CoV-2 virus. Typically in these cases the syndrome manifests four to six weeks after infection, producing high fever, organ dysfunction, and strongly elevated markers of inflammation.

Interestingly the systems-level analysis described in the study reveals that these children have an immunological profile that is quite distinct from both the symptomatically overlapping Kawasaki disease, and severe Covid-19 in adults. These findings could be used to develop better immunomodulatory therapies for MIS-C.

These findings could be used to develop better immunomodulatory therapies for mitigating hyperinflammation and long-term tissue damage.

Download the article here

Related Articles

Join FREE today and become a member
of Drug Discovery World

Membership includes:

  • Full access to the website including free and gated premium content in news, articles, business, regulatory, cancer research, intelligence and more.
  • Unlimited App access: current and archived digital issues of DDW magazine with search functionality, special in App only content and links to the latest industry news and information.
  • Weekly e-newsletter, a round-up of the most interesting and pertinent industry news and developments.
  • Whitepapers, eBooks and information from trusted third parties.
Join For Free